Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
Carcinogenesis|September 2, 2003
Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonistTom C Martinsen, Shiro Kawase, Rolf Håkanson, et al.Journal of Cellular Biochemistry|September 2, 2011
Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient miceReidar Fossmark, Astrid K Stunes, Christiane Petzold, et al.Experimental and Molecular Pathology|March 5, 2014
The PAS positive material in gastric cancer cells of signet ring type is not mucinØystein Sørdal, Gunnar Qvigstad, Ivar Skjåk Nordrum, et al.Clinical and Translational Gastroenterology|March 20, 2026
Full title: Telomere length in celiac disease in a population-based cohort - a HUNT studyReidar Fossmark, Henrik Hjorth-Hansen, Lisa Lirussi, et al.Endocrine-Related Cancer|October 10, 2014
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatmentAnnemiek Walenkamp, Guillermo Crespo, Felipe Fierro Maya, et al.British Journal of Clinical Pharmacology|October 6, 2016
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritisMalcolm Boyce, Andrew R Moore, Liv Sagatun, et al.International Journal of Molecular Sciences|February 7, 2020
Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H<sup>+</sup>/K<sup>+</sup>ATPase Beta Subunit Knockout MiceKristin Matre Aasarød, Helge Lyder Waldum, Astrid Kamilla Stunes, et al.European Journal of Gastroenterology & Hepatology|August 6, 2008
Changes in gene expression of gastric mucosa during therapeutic acid inhibitionKristin G Nørsett, Astrid Laegreid, Waclaw Kusnierczyk, et al.BMC Endocrine Disorders|May 28, 2011
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized ratsAstrid K Stunes, Irene Westbroek, Björn I Gustafsson, et al.Plastic and Reconstructive Surgery|December 9, 2025
Mechanical Manipulation of Fat: From Lipoaspirate to SVF ConcentrateKjersti Ausen, Anne D B Rø, Gunnhild V Leirvik, et al.Pageof 11